dasatinib
Interviews and expert commentary tagged “dasatinib” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Live Report from ASH:<br />Dasatinib Effective At Two Years’ Follow Up in Chronic Phase CML
Richard Stone RICHARD STONE, Dana-Farber Cancer Institute, Boston GEORGE CANELLOS, Dana-Farber Cancer Institute New data shows that dasatinib is giving durable responses in patients with chronic phase
Dec. 15, 2006: Reporting from the American Society of Hematology 48th Annual Meeting, Orlando, Florida, December 9-12, 2006
Martin Müller Charles Linker Andreas Hochhaus Christian Buske Katarina Le Blanc Stephen Emerson Alessandro Vannucchi Kanti Rai Richard Schlenk BCR-ABL Mutations After Imatinib Failure: Impact on Respo
ASCO Audio Journal of Oncology – September 1st, 2006
Mark Socinski Bruce Johnson Neil Shah Doug Smith Sunitinib Multi-Targeted Oral Anti-Angiogenic Therapy Responses in Lung Cancer REFERENCE: Abstract 7001 Mark A. Socinski, Univerisity of North Carolina
Audio Journal of Oncology – June 3rd 2006, from the ASCO Annual Meeting in Atlanta, June 2-6; in the company of George Canellos
George Canellos Carmela Pepe John Goldman Roy Herbst Sandra Horning George Canellos, from the Dana-Farber Cancer Institute in Boston, joins Derek Thorne to talk about the first day’s news at the